Familial Cancer

, Volume 5, Issue 3, pp 275–285 | Cite as

Current ideas in desmoid tumours

  • N. Julian H. Sturt
  • Susan K. ClarkEmail author


Desmoid tumours are rare neoplasms of fibroblastic origin which arise with disproportionate frequency in patients with familial adenomatous polyposis (FAP). They are thought to develop in about 10–25% of FAP patients and may be the leading cause of death amongst those who have undergone colectomy. Risk factors include trauma, having a distal germline APC mutation, having a family history of desmoids, and probably oestrogens. In very high-risk individuals there may be a case for delay of colectomy or chemoprophylaxis at the time of surgery. Desmoids are now known to be true neoplasms but with normal telomere length and telomerase activity. FAP-associated tumours seem to carry biallelic APC mutations, one of which lies in the distal part of the gene. Such loss of wild-type APC seems to occur relatively late in tumour development. It is likely that β-catenin plays an important role in tumourigenesis. FAP-associated desmoids tend to arise in the abdomen or abdominal wall. CT scanning gives the best information on tumour anatomy whilst T2-weighted MRI indicates likely behaviour. Treatment may simply consist of observation. Otherwise, usual first-line therapy is with sulindac with or without an anti-oestrogen. Cytotoxic chemotherapy is an option in unresectable tumours. Surgery is a reasonable first-line treatment in abdominal wall tumours but is risky for intra-abdominal tumours and may necessitate massive small bowel resection. Desmoids are the greatest remaining challenge in the management of FAP and further research into their aetiology needs to be combined with multicentre clinical trials of new treatments in order to improve management of the disease.


desmoid tumour familial adenomatous polyposis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Reitamo, JJ, Scheinin, TM, Hayry, P 1986The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumorAm J Surg1512307PubMedCrossRefGoogle Scholar
  2. 2.
    Gurbuz, AK, Giardello, FM, Petersen, GM,  et al. 1994Desmoid tumours in familial adenomatous polyposisGut3537781PubMedGoogle Scholar
  3. 3.
    Lofti, AM, Dozois, RR, Gordon, H,  et al. 1989Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatmentInt J Colorectal Dis4306CrossRefGoogle Scholar
  4. 4.
    Bertario, L, Russo, A, Sala, P,  et al. 2001Genotype and phenotype factors as determinants of desmoid tumours in patients with familial adenomatous polyposisInt J Cancer951027PubMedCrossRefGoogle Scholar
  5. 5.
    Heinimann, K, Mullhaupt, B, Weber, W,  et al. 1998Phenotypic differences in familial adenomatous polyposis based on APC germline mutation statusGut43675679PubMedCrossRefGoogle Scholar
  6. 6.
    Friedl, W, Caspari, R, Sengteller, M,  et al. 2001Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP familiesGut48515521PubMedCrossRefGoogle Scholar
  7. 7.
    Nugent, KP, Spigelman, AD, Phillips, RKS 1993Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposisDis Colon Rectum36105962PubMedCrossRefGoogle Scholar
  8. 8.
    Arvanitis, ML, Jagelman, DG, Fazio, VW,  et al. 1990Mortality in patients with familial adenomatous polyposisDis Colon Rectum3363942PubMedCrossRefGoogle Scholar
  9. 9.
    Bertario, L, Presciuttini, S, Sala, P,  et al. 1994Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian registry of familial polyposis writing committeeSemin Surg Oncol1022534PubMedGoogle Scholar
  10. 10.
    Clark, SK, Phillips, RKS 1996Desmoids in familial adenomatous polyposisBr J Surg831494504PubMedGoogle Scholar
  11. 11.
    Lynch, HT, Fitzgibbons, R,Jr 1996Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature reviewAm J Gastroenterol912598601PubMedGoogle Scholar
  12. 12.
    Clark, SK, Smith, TG, Katz, DE,  et al. 1998Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposisBr J Surg859703PubMedCrossRefGoogle Scholar
  13. 13.
    Reitamo, JJ, Hayry, P, Nykyri, E,  et al. 1982The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish populationAm J Clin Pathol7766573PubMedGoogle Scholar
  14. 14.
    Hayry, P, Reitamo, JJ, Totterman, S,  et al. 1982The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behaviorAm J Clin Pathol7767480PubMedGoogle Scholar
  15. 15.
    Klemmer, S, Pascoe, L, Decosse, J 1987Occurrence of desmoids in patients with familial adenomatous polyposis of the colonAm J Med Genet2838592PubMedCrossRefGoogle Scholar
  16. 16.
    Sturt NJH, Gallagher MC, Bassett P et al., 2004 Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis (FAP) independent of the APC germline mutation. Submitted for publicationGoogle Scholar
  17. 17.
    McAdam, WA, Goligher, JC 1970The occurrence of desmoids in patients with familial polyposis coliBr J Surg5761831PubMedGoogle Scholar
  18. 18.
    Lim, CL, Walker, MJ, Mehta, RR,  et al. 1986Estrogen and antiestrogen binding sites in desmoid tumorsEur J Cancer Clin Oncol225837PubMedCrossRefGoogle Scholar
  19. 19.
    Tonelli, F, Valanzano, R, Brandi, ML 1994Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in␣vitro studySurgery1154739PubMedGoogle Scholar
  20. 20.
    Miyoshi, Y, Ando, H, Nagase, H,  et al. 1992Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patientsProc Natl Acad Sci USA8944526PubMedCrossRefGoogle Scholar
  21. 21.
    Nagase, H,  et al. 1992Correlation between the location of germline mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patientsCancer Res5240557PubMedGoogle Scholar
  22. 22.
    Caspari, R, Olschwang, S, Friedl, W,  et al. 1995Familial Adenomatous Polyposis: desmoid tumours and lack of opthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444Hum Mol Genet433740PubMedGoogle Scholar
  23. 23.
    Davies, DR, Armstrong, JG, Thakker, N,  et al. 1995Severe Gardner syndrome in families with mutations restricted to a specific region of the APC geneAm J Hum Genet5711518PubMedGoogle Scholar
  24. 24.
    Scott, RJ, Froggatt, NJ, Trembath, RC,  et al. 1996Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutationHum Mol Genet519214PubMedCrossRefGoogle Scholar
  25. 25.
    Eccles, DM, Luijt, R, Breukel, C,  et al. 1996Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC geneAm J Hum Genet591193201PubMedGoogle Scholar
  26. 26.
    Couture, J, Mitri, A, Lagace, R,  et al. 2000A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumourClin Genet5720512PubMedCrossRefGoogle Scholar
  27. 27.
    Bertario, L, Russo, A, Sala, P,  et al. 2003Multiple approach to the exploration of genotype–phenotype correlations in familial adenomatous polyposisJ Clin Oncol211698707PubMedCrossRefGoogle Scholar
  28. 28.
    Dobbie, Z, Spycher, M, Mary, J-L,  et al. 1996Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC geneJ Med Genet3327480PubMedCrossRefGoogle Scholar
  29. 29.
    Houlston, R, Crabtree, M, Phillips, R,  et al. 2000Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genesGut4815CrossRefGoogle Scholar
  30. 30.
    Soravia, C, Berk, T, McLeod, RS,  et al. 2000Desmoid disease in patients with familial adenomatous polyposisDis Colon Rectum433639PubMedCrossRefGoogle Scholar
  31. 31.
    Fodde, R, Edelmann, W, Yang, K,  et al. 1994A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumorsProc Natl Acad Sci USA91896973PubMedCrossRefGoogle Scholar
  32. 32.
    Smits, R, Houven Oordt, W, Luz, A,  et al. 1998Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cystsGastroenterology11427583PubMedCrossRefGoogle Scholar
  33. 33.
    Smits, R, Kartheuser, A, Jagmohan-Changur, S,  et al. 1997Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesisCarcinogenesis183217PubMedCrossRefGoogle Scholar
  34. 34.
    Tolg, C, Poon, R, Fodde, R,  et al. 2003Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumour)Oncogene22687382PubMedCrossRefGoogle Scholar
  35. 35.
    Luijt, RB, Meera Khan, P, Vasen, HFA,  et al. 1996Germline mutations in the 3’ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coliHum Genet9872734PubMedCrossRefGoogle Scholar
  36. 36.
    Soravia, C, Berk, T, Madlensky, L,  et al. 1998Genotype–phenotype correlations in attenuated adenomatous polyposis coliAm J Hum Genet621290301PubMedCrossRefGoogle Scholar
  37. 37.
    Middleton, SB, Pack, K, Phillips, RK 2000Telomere length in familial adenomatous polyposis-associated desmoidsDis Colon Rectum4315359PubMedCrossRefGoogle Scholar
  38. 38.
    Li, M, Cordon-Cardo, C, Gerald, WL,  et al. 1996Desmoid fibromatosis is a clonal processHum Pathol2793943PubMedCrossRefGoogle Scholar
  39. 39.
    Middleton, SB, Frayling, IM, Phillips, RK 2000Desmoids in familial adenomatous polyposis are monoclonal proliferationsBr J Cancer8282732PubMedCrossRefGoogle Scholar
  40. 40.
    Miyaki, M, Konishi, M, Kikuchi-Yanoshita, R,  et al. 1993Coexistence of somatic and germ-line mutations of APC gene in desmoid tumours from patients with familial adenomatous polyposisCancer Res53507982PubMedGoogle Scholar
  41. 41.
    Palmirotta, R, Curia, MC, Esposito, DL,  et al. 1995Novel mutations and inactivation of both alleles of the APC gene in desmoid tumoursHum Mol Genet4197981PubMedGoogle Scholar
  42. 42.
    Lamlum, H, Ilyas, M, Rowan, A,  et al. 1999The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of germline mutation: a new facet to Knudson’s ‘two hit’ hypothesisNat Med510715PubMedCrossRefGoogle Scholar
  43. 43.
    Clark SK. Studies in desmoid disease in familial adenomatous polyposis. MD thesis, University of Cambridge, 1998Google Scholar
  44. 44.
    Miyoshi, Y, Iwao, K, Nawa, G,  et al. 1998Frequent mutations in the beta-catenin gene in desmoid tumours from patients without familial adenomatous polyposisOncol Res105914PubMedGoogle Scholar
  45. 45.
    Tejpar, S, Nollet, F, Li, C,  et al. 1999Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosisOncogene18661520PubMedCrossRefGoogle Scholar
  46. 46.
    Montgomery, E, Torbenson, MS, Kaushal, M,  et al. 2002Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritisAm J Surg Pathol261296301PubMedCrossRefGoogle Scholar
  47. 47.
    Cheon, SS, Cheah, AYL, Turley, S,  et al. 2002b-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous woundsProc Natl Acad Sci USA9969738PubMedCrossRefGoogle Scholar
  48. 48.
    Larramendy, ML, Virolainen, M, Tukiainen, E,  et al. 1998Chromosome band 1q21 is recurrently gained in desmoid tumorsGenes Chromosomes Cancer231836PubMedCrossRefGoogle Scholar
  49. 49.
    Brandal, P, Micci, F, Bjerkehagen, B,  et al. 2003Molecular cytogenetic characterization of desmoid tumorsCancer Genet Cytogenet14617PubMedCrossRefGoogle Scholar
  50. 50.
    Church, JM 1995Desmoid tumours in patients with familial adenomatous polyposisSemin Colon Rectal Surg62932Google Scholar
  51. 51.
    Middleton, SB, Clark, SK, Matravers, P,  et al. 2003Stepwise progression of familial adenomatous polyposis-associated desmoid precursor lesions demonstrated by a novel CT scoring systemDis Colon Rectum464815PubMedCrossRefGoogle Scholar
  52. 52.
    Healy, JC, Reznek, RH, Clark, SK,  et al. 1997MR appearances of desmoid tumors in familial adenomatous polyposisAJR Am J Roentgenol16946572PubMedGoogle Scholar
  53. 53.
    Phillips, RKS, Wallace, MH, Lynch, PM,  et al. 2002A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposisGut5085760PubMedCrossRefGoogle Scholar
  54. 54.
    Friend, WG 1990Sulindac suppression of colorectal polyps in Gardener’s syndromeAm Fam Physician418914PubMedGoogle Scholar
  55. 55.
    Poon, R, Smits, R, Li, C,  et al. 2001Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor)Oncogene2045160PubMedCrossRefGoogle Scholar
  56. 56.
    Tsukada, K, Church, JM, Jagelman, DG,  et al. 1992Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposisDis Colon Rectum352933PubMedCrossRefGoogle Scholar
  57. 57.
    Janinis, J, Patriki, M, Vini, L,  et al. 2003The pharmacological treatment of aggressive fibromatosis: a systematic reviewAnn Oncol1418190PubMedCrossRefGoogle Scholar
  58. 58.
    Tonelli, F, Ficari, F, Valanzano, R,  et al. 2003Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifeneTumori893916PubMedGoogle Scholar
  59. 59.
    Lindor, NM, Dozois, R, Nelson, H,  et al. 2003Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidoneAm J Gastroenterol98186874PubMedCrossRefGoogle Scholar
  60. 60.
    Mace, J, Sybil Biermann, J, Sondak, V,  et al. 2002Response of extraabdominal desmoid tumors to therapy with imatinib mesylateCancer9523739PubMedCrossRefGoogle Scholar
  61. 61.
    Seiter, K, Kemeny, N 1993Successful treatment of a desmoid tumour with doxorubicinCancer7122424PubMedCrossRefGoogle Scholar
  62. 62.
    Risum, S, Bulow, S 2003Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposisColorectal Dis55856PubMedCrossRefGoogle Scholar
  63. 63.
    Weiss, A, Lackman, R 1989Low-dose chemotherapy of desmoid tumoursCancer6411924PubMedCrossRefGoogle Scholar
  64. 64.
    Azzarelli, A, Gronchi, A, Bertulli, R,  et al. 2001Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosisCancer92125964PubMedCrossRefGoogle Scholar
  65. 65.
    Clark, SK, Neale, KF, Landgrebe, JC,  et al. 1999Desmoid tumours complicating familial adenomatous polyposisBr J Surg8611859PubMedCrossRefGoogle Scholar
  66. 66.
    Tzakis, AG, Tryphonopoulos, P, Faria, W,  et al. 2003Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesenteryJ Am Coll Surg1977706PubMedCrossRefGoogle Scholar
  67. 67.
    Clark, TW 2003Percutaneous chemical ablation of desmoid tumorsJ Vasc Interv Radiol1462934PubMedGoogle Scholar
  68. 68.
    Bright-Thomas, RM, Agrawal, A, Hargest, R 2002Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposisBr J Surg8915639PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  1. 1.Polyposis RegistryCancer Research UK Colorectal Cancer Unit, St Mark’s HospitalHarrowUK
  2. 2.Consultant Surgeon, Polyposis RegistryCancer Research UK Colorectal Cancer Unit, St Mark’s HospitalHarrowUK

Personalised recommendations